Home

LOUIS C BOCK

CIK 1279735 · last filed 2022-03-09

LOUIS C BOCK is a corporate insider who has filed 42 SEC Form 4 insider transactions across 6 companies since 2007. Across all open-market trades the lifetime net is +$11.5M, making them a net buyer over the disclosed history. 3 SEC filings were submitted jointly with KATE MITCHELL.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

42

Lifetime Open-Market Net

$11.47M

Filer Profile

Reported Address
C/O BANKAMERICA VENTURES
950 TOWER LANE STE 700
FOSTER CITY, CA 94404
Related Filers
KATE MITCHELL — 3 joint filings, latest 2010-04-28
Rory O'Driscoll — 3 joint filings, latest 2010-04-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZOGENIX, INC. (ZGNX) Delisted Director 12,841 $26.68 $342.6K $8.75M 14 2021-05-28
Orexigen Therapeutics, Inc. (OREX) Delisted Director 2,838 — — -$3.34M 20 2017-07-18
Scorpius Holdings, Inc. (HTBX) Delisted Director — $2.38 — $0 1 2016-01-13
Horizon Therapeutics Public Ltd Co (HZNP) Delisted Director 1,888,519 $116.30 $219.63M $2.84M 1 2011-08-04
Pernix Sleep, Inc. (SOMX) Delisted 10%+ Owner 311,528 — — $3.22M 1 2009-07-09
SGX PHARMACEUTICALS, INC. (SGXP) Delisted Director 2,546,747 — — $0 2 2008-06-12

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-03-09 — Disp (D) — $0
2021-05-28 ZOGENIX, INC. (ZGNX) Delisted Grant (A) — $0 EDGAR
2020-06-29 ZOGENIX, INC. (ZGNX) Delisted Grant (A) — $0 EDGAR
2019-05-28 ZOGENIX, INC. (ZGNX) Delisted Grant (A) — $0 EDGAR
2018-05-24 ZOGENIX, INC. (ZGNX) Delisted Grant (A) — $0 EDGAR
2018-03-14 ZOGENIX, INC. (ZGNX) Delisted Mixed — -$718.7K EDGAR
2017-07-18 Orexigen Therapeutics, Inc. (OREX) Delisted Grant (A) — $0 EDGAR
2017-05-23 ZOGENIX, INC. (ZGNX) Delisted Grant (A) — $0 EDGAR
2016-07-15 ZOGENIX, INC. (ZGNX) Delisted Grant (A) — $0 EDGAR
2016-07-14 Orexigen Therapeutics, Inc. (OREX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.